4Moreno C,Cuesta-Herranz J Fernandez-Tavora L,et al.Immunotherapy safety:a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases.Clin-Exp-Allergy,2004 ; 34 (4):527 ～ 31
5Agostinis F,Tellarini L,Canonica GW,et al.Safety of sublingual immunotherapy with a monomeric allergoid in very young children.Allergy,2005 ; 60 (1):133
6Nouri-Aria KT,Wachholz PA,Francis JN,et al.Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.J Immunol,2004 ; 172(5):3252～3259
7Hall G,Houghton CG,Rahbek JU,et al.Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production.Vaccine,2003,21 (5-6):549 ～ 61
8Marshall JD,Abtahi S,Eiden JJ,et al.Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes TH1 cytokine expression while downregulating TH2 cytokine expression in PBMCs from human patients with ragweed allergy.J Allergy Clin Immunol,2001; 108(2):191 ～ 197
9Tulic MK,Fiset PO,Christodoulopoulos P,et al.Amb a 1-immunostimulatory loigodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.J Allergy Clin Immunol,2004;113(2):235～241
3Aivaresz- CuestaE,Bousquet J,Canonica GW.Standards for practicul Allergen- specific immunotherapy[].Allergy.2006
4A kdis M,Blaser K,A kdis CA.T regulatory cells in allergy:novelconcepts in the pathogenesis,prevention,and treatm ent of allergic diseases[].J Allergy Clin Im m unol.2005
5AA Cruz,T Popov,R Pawankar,I Annesi-Maesano,W Fokkens,J Kemp.Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN[].Allergy.2007
6Douglass JA,O′Hehir RE.Diagnosis,treatment and prevention of allergic disease:the basics[].Medical Journal of Australia.2006
